XENE
Overvalued by 95.7% based on the discounted cash flow analysis.
Market cap | $3.05 Billion |
---|---|
Enterprise Value | $2.93 Billion |
Dividend Yield | $- (-) |
Earnings per Share | $-3.01 |
Beta | 1.14 |
Outstanding Shares | 78,953,445 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -11.24 |
---|---|
PEG | -24.31 |
Price to Sales | - |
Price to Book Ratio | 4.95 |
Enterprise Value to Revenue | 390.77 |
Enterprise Value to EBIT | -9.21 |
Enterprise Value to Net Income | -11 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0.02 |
No data
No data